JAK-2 Mutation (CMPD) (V617F)
Guaranteed Safe Checkout
JAK-2 Mutation (CMPD) (V617F)
Detect myeloproliferative disorders with the JAK2 Mutation (CMPD) (V617F) Test at Lucid Medical Diagnostics in Hyderabad. This advanced molecular genetic test identifies the JAK2 V617F mutation, a key genetic alteration associated with chronic myeloproliferative neoplasms (MPNs) such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. The test supports accurate diagnosis, disease classification, prognosis, and treatment planning for patients with suspected blood disorders. Using advanced PCR-based molecular diagnostic technology and stringent quality standards, our experienced laboratory team provides accurate, reliable, and timely results to support informed clinical decisions and improve patient care outcomes.
Home Sample Collection Available
Get Reports
